Club drugs and HIV/STI infection: A new public health concern in China

Fudan University Journal of Medical Sciences

Volumn 39, Issue 6, 2012, Pages 551-557

  Ding, Ying Ying ^a   He, Na ^a,b  

^a FUDAN UNIVERSITY   (China)

^b EMORY UNIVERSITY   (United States)

Author keywords

Club drugs; HIV AIDS; New type drugs; Risky sexual behaviors

Indexed keywords

EID: 84871120662     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-8467.2012.06.001     Document Type: Article

References (78)

1. Degenhardt L, Copeland J, Dillon P. Recent trends in the use of "club drugs": an Australian review [J]. Subst Use Misuse, 2005, 40(9-10): 1241-1256.
2. United Nations Office on Drugs and Crime (UNODC). 2010 patterns and trends of amphetamine-type stimulants and other drugs (Asia and the Pacific). A Report from the Global SMART Programme[EB/OL]. [2012-10-18] http://www.unodc.org/documents/scientific/ATS_Report_2010_web.pdf
3. United Nations Office on Drugs and Crime (UNODC). 2011 Patterns and trends of amphetamine-type stimulants and other drugs: Asia and the Pacific[EB/OL]. [2012-10-18] http://www.unodc.org/documents/ATS/ATS_Global_Assessment_2011.pdf.
4. Fernández M I, Bowen G S, Varga L M, et al. High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami, Florida [J]. Subst Use Misuse, 2005, 40(9-10): 1347-1362.
5. Parsons J T, Kelly B C, Wells B E. Differences in club drug use between heterosexual and lesbian/bisexual females [J]. Addict Behav, 2006, 31(12): 2344-2349.
6. MOH/UNAIDS/WHO. A Joint Assessment of HIV/AIDS Prevention, treatment and care in China (2007)[EB/OL]. (2007-12-01)[2012-10-18] http: //www.chinaids.org.cn/n443289/n443292/appendix/2008111111551.pdf.
7. MOH/UNAIDS/WHO. A Joint Assessment of HIV/AIDS Prevention, treatment and care in China (2011) [EB/OL]. [2012-10-18] http://www.moh.gov.cn/publicfiles/business /cmsresources/mohyzs/cmsrsdocument/doc13944.pdf.
8. Colfax G, Guzman R. Club drugs and HIV infection: a review [J]. Clin Infect Dis, 2006, 42(10): 1463-1469.
9. Zuckerman M D, Boyer E W. HIV and club drugs in emerging adulthood [J]. Curr Opin Pediatr, 2012, 24(2): 219-224.
10. Koesters S C, Rogers P D, Rajasingham C R. MDMA ('ecstasy') and other 'club drugs'. The new epidemic [J]. Pediatr Clin North Am, 2002, 49(2): 415-433.
11. Smith K M, Larive L L, Romanelli R. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and γ-hydroxybutyrate [J]. Am J Health-Syst Pharm, 2002, 59(11): 1067-1076.
12. Lankenau S E, Clatts M C. Ketamine injection among high risk youth: preliminary findings from New York City [J]. J Drug Issues, 2002, 32(3): 893-905.
13. Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia [J]. Drug Alcohol Rev, 2008, 27(3): 243-252.
14. NIDA. Club drugs[EB/OL]. [2012-10-18] http://www.drugabuse.gov/drugs-abuse/club-drugs.
15. Gahlinger P M. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine [J]. Am Fam Physician, 2004, 69(11): 2619-2626.
16. Romanelli F, Smith K M, Pomeroy C. Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men [J]. Top HIV Med, 2003, 11(1): 25-32.
17. Sanders B. Young people, drugs and clubs [M]//Sanders B. Drugs, clubs and young people: sociological and public health perspectives. Aldershot: Ashgate Publishing Ltd., 2006: 6.
18. Rome E S. It's a rave new world: rave culture and illicit drug use in the young [J]. Cleve Clin J Med, 2001, 68(6): 541-550.
19. Frei M. Party drugs-use and harm reduction[J]. Aust Fam Physician, 2010, 39(8): 548-552.
20. Riley S C, James C, Gregory D, et al. Patterns of recreational drug use at dance events in Edinburgh, Scotland [J]. Addiction, 2001, 96(7): 1035-1047.
21. Wu L T, Schlenger W E, Galvin D M. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths [J]. Drug Alcohol Depend, 2006, 84(1): 102-113.
22. Darke S, Kaye S, McKetin R, et al. Major physical and psychological harms of methamphetamine use [J]. Drug Alcohol Rev, 2008, 27(3): 253-262.
23. Freese T E, Miotto K, Reback C J. The effects and consequences of selected club drugs [J]. J Subst Abuse Treat, 2002, 23(2): 151-156.
24. Morgan M J. Ecstasy (MDMA): a review of its possible persistent psychological effects [J]. Psychopharmacology (Berl), 2000, 152(3): 230-248.
25. Rawson R, Huber A, Brethen P, et al. Methamphetamine and cocaine users: differences in characteristics and treatment retention [J]. J Psychoactive Drugs, 2000, 32(2): 233-238.
26. Hendrickson J C, Gerstein D R. Criminal involvement among young male ecstasy users [J]. Subst Use Misuse, 2005, 40(9-10): 1557-1575.
27. McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants [J]. Drug Alcohol Rev, 2008, 27(3): 277-285.
28. Drumright L N, Patterson T L, Strathdee S A. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review[J]. Subst Use Misuse, 2006, 41(10-12): 1551-1601.
29. Jerome RC, Halkitis PN, Siconolfi DE. Club drug use, sexual behavior, and HIV seroconversion: a qualitative study of motivations [J]. Subst Use Misuse, 2009, 44(3): 431-447.
30. Lankenau S E, Sanders B, Bloom J J, et al. First injection of ketamine among young injection drug users (IDUs) in three U.S. cities [J]. Drug Alcohol Depend, 2007, 87(2-3): 183-193.
31. Marshall B D, Wood E, Shoveller J A, et al. Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies [J]. Prev Sci, 2011, 12(2): 173-180.
32. Topp L, Hall W, Hando J. Is there a dependence syndrome for ecstasy? NDARC Technical Report No.51[EB/OL]. [2012-10-18] http://www.ndarc.med.unsw.edu.au/sites/ ndarc.cms.med.unsw.edu.au/files/ndarc/resources/TR.051.pdf
33. Cheng W S, Garfein R S, Semple S J, et al. Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users [J]. J Psychoactive Drugs, 2010, 42(1): 11-18.
34. Miller C L, Kerr T, Fischer B, et al. Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting [J]. J Adolesc Health, 2009, 44(3): 302-304
35. Anglin M D, Burke C, Perrochet B, et al. History of the methamphetamine problem [J]. J Psychoactive Drugs, 2000, 32(2): 137-141.
36. Halkitis P N, Shrem M T, Martin F W. Sexual behavior patterns of methamphetamine using gay and bisexual men in New York City [J]. Subst Use Misuse, 2005, 40(5): 703-719.
37. Green A I. "Chem friendly": the institutional basis of "club drug" use in a sample of urban gay men[J]. Deviant Behav, 2003, 24(5): 427-447.
38. Kurtz S P. Post-circuit blues: motivations and consequences of crystal meth use among gay men in Miami[J]. AIDS Behav, 2005, 9(1): 63-72.
39. Semple S J, Patterson T L, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men [J]. J Subst Abuse Treat, 2002, 22(3): 149-156.
40. Semple SJ, Zians J, Strathdee S A, et al. Sexual marathons and methamphetamine use among HIV-positive men who have sex with men [J]. Arch Sex Behav, 2009, 38(4): 583-590.
41. Lorvick J, Martinez A, Gee L, et al. Sexual and injection risk among women who inject methamphetamine in San Francisco [J]. J Urban Health, 2006, 83(3): 497-505.
42. Rawstorne P, Digiusto E, Worth H, et al. Associations between crystal methamphetamine use and potentially unsafe sexual activity among gay men in Australia [J]. Arch Sex Behav, 2007, 36(5): 646-654.
43. Steinberg J K, Grella C E, Boudov M R, et al. Methamphetamine use and high-risk sexual behaviors among incarcerated female adolescents with a diagnosed STD [J]. J Urban Health, 2011, 88(2): 352-364.
44. Zule W A, Costenbader E C, Meyer W J, et al. Methamphetamine use and risky sexual behaviors during heterosexual encounters [J]. Sex Transm Dis, 2007, 34(9): 689-694.
45. Taylor M M, Aynalem G, Smith L V, et al. Methamphetamine use and sexual riskbehaviours among men who have sex with men diagnosed with early syphilis in Los Angeles County [J]. Int J STD AIDS, 2007, 18(2): 93-97.
46. Zapata L B, Hillis S D, Marchbanks P A, et al. Methamphetamine use is independently associated with recent risky sexual behaviors and adolescent pregnancy [J]. J Sch Health, 2008, 78(12): 641-648.
47. Purcell D W, Moss S, Remien R H, et al. Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: differences by serostatus of casual partners [J]. AIDS, 2005, 19 (Suppl 1): S37-S47.
48. Hirshfield S, Remien R H, Walavalkar I, et al. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case-control study [J]. J Med Internet Res, 2004, 6(4): e41.
49. Buchacz K, McFarland W, Kellogg TA, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco [J]. AIDS, 2005, 19(13): 1423-1424.
50. Shoptaw S, Reback C J, Frosch D L, et al. Stimulant abuse treatment as HIV prevention [J]. J Addict Dis, 1998, 17(4): 19-32.
51. Shoptaw S, Reback C J, Peck J A, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men [J]. Drug Alcohol Depend, 2005, 78(2): 125-134.
52. Teter C J, Guthrie S K. A comprehensive review of MDMA and GHB: two common club drugs [J]. Pharmacotherapy, 2001, 21(12): 1486-1513.
53. Levy K B, O'Grady K E, Wish E D, et al. An in-depth qualitative examination of the ecstasy experience: Results of a focus group with ecstasy-using college students [J]. Subst Use Misuse, 2005, 40(9-10): 1427-1441
54. McElrath K. MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk [J]. Subst Use Misuse, 2005, 40(9-10): 1461-1477.
55. Klitzman R L, Pope H G Jr, Hudson J I. MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men [J]. Am J Psychiatry, 2000, 157(7): 1162-1164.
56. Mattison, A M, Ross, M W, Wolfson T, et al. Circuit party attendance, club drug use, and unsafe sex in gay men [J]. J Subst Abuse, 2001, 13(1-2): 119-126.
57. Rusch M, Lampinen T M, Schilder A, et al. Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role [J]. Sex Transm Dis, 2004, 31(8): 492-498.
58. Waldo C R, McFarland W, Katz M H, et al. Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II [J]. JAIDS, 2000, 24(2): 168-174.
59. Klitzman R L, Greenberg J D, Pollack L M, et al. MDMA ("ecstasy") use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City [J]. Drug Alcohol Depend, 2002, 66(2): 115-125.
60. Novoa R A, Ompad D C, Wu Y, et al. Ecstasy use and its association with sexual behaviors among drug users in New York City [J]. J Community Health, 2005, 30(5): 331-343.
61. Sterk C E, Klein H, Elifson K W. Young adult Ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice [J]. J Psychoactive Drugs, 2008, 40(3): 237-244.
62. Hittner J B, Schachne E R. Meta-analysis of the association between ecstasy use and risky sexual behavior[J]. Addict Behav, 2012, 37(7): 790-796.
63. Kohrrs R, Duriex M E. Ketamine: teaching an old drug new tricks [J]. Anesth Analg, 1998, 87(5): 1186-1193.
64. McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants [J]. Drug Alcohol Rev, 2008, 27(3): 277-285.
65. Kvarnstrom A, Karlsten R, Quiding H, et al. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain [J]. Acta Anaesthesiol Scand, 2003, 47(7): 868-877.
66. Oser C, Havens J, Staton-Tindall M, et al. HIV Sexual risk behaviors among ketamine and non-ketamine using criminal offenders prior to prison entry [J]. Addict Res Theory, 2008, 16(3): 289-302.
67. Grov C, Kelly B C, Parsons J T. Polydrug use among club-going young adults recruited through time-space sampling [J]. Subst Use Misuse, 2009, 44(6): 848-864.
68. Bao Y P, Liu Z M, Lu L. Review of HIV and HCV infection among drug users in China [J]. Curr Opin Psychiatry, 2010, 23(3): 187-194.
69. Jia Z, Wang W, Dye C, et al. Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China [J]. Am J Drug Alcohol Abuse, 2010, 36(2): 130-133.
70. Yang X, Xia G. Causes and consequences of increasing club drug use in China: a descriptive assessment [J]. Subst Use Misuse, 2010, 45(1-2): 224-223.
71. Ye Y. Analysis of polydrug abuse among heroin addicts [J]. Chin J Drug Depend, 2002, 2(11): 137-140.
72. National Institute on Drug Dependence and Drug Abuse Surveillance Center. Report of drug surveillance 2003[EB/OL]. (2005-06-14)[2012-10-18] http: //www.qsn365.com/qsn365/jindu.do?todo=read&docID=547
73. National Narcotics Control Commission. 2011 Annual Report on Drug Control in China[EB/OL]. (2011-06-02)[2012-10-18] http://www.mps.gov.cn/n16/n80209/n80481/n804535/2804926.html
74. Wong FY, He N, Huang ZJ, et al. Migration and illicit drug use among two types of male migrants in Shanghai, China [J]. Sex Transm Dis, 2011, 38(1): 57-62.
75. Liu S, Detels R. Recreational drug use: an emerging concern among venue-based male sex workers in China[J]. Sex Transm Dis, 2012, 39(4): 251-252.
76. Liao M, Jiang Z, Zhang X, et al. Syphilis and methamphetamine use among female sex workers in Shandong Province, China[J]. Sex Transm Dis, 2011, 38(1): 57-62.
77. Zhuo X, Cang Y, Yan H, et al. The prevalence of drugs in motor vehicle accidents and traffic violations in Shanghai and neighboring cities [J]. Accid Anal Prev, 2010, 42(6): 2179-2184.
78. Ding Y, He N, Zhu W, et al. Sexual risk behaviors among club drug users in Shanghai, China: prevalence and correlates[J]. AIDS Behav (in submission).